Hindustan Bio Sciences Ltd

BOM:532041 (India)  
₹ 8.55 (+4.4%) May 24
61.07
P/B:
12.69
Market Cap:
₹ 87.64M ($ 1.05M)
Enterprise V:
₹ 113.48M ($ 1.36M)
Volume:
26.30K
Avg Vol (2M):
18.82K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hindustan Bio Sciences Ltd ( ) from 1996 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hindustan Bio Sciences stock (BOM:532041) PE ratio as of May 27 2024 is 61.07. More Details

Hindustan Bio Sciences Ltd (BOM:532041) PE Ratio (TTM) Chart

To

Hindustan Bio Sciences Ltd (BOM:532041) PE Ratio (TTM) Historical Data

Total 1227
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Hindustan Bio Sciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-27 61.1 2024-03-14 56.1
2024-05-24 61.1 2024-03-13 57.2
2024-05-23 58.5 2024-03-12 58.4
2024-05-22 57.9 2024-03-11 59.5
2024-05-21 59.6 2024-03-07 60.6
2024-05-17 59.0 2024-03-06 61.9
2024-05-16 59.9 2024-03-05 63.1
2024-05-15 59.9 2024-03-04 64.4
2024-05-14 60.7 2024-03-01 65.7
2024-05-13 60.8 2024-02-29 66.9
2024-05-10 61.1 2024-02-28 68.3
2024-05-09 59.3 2024-02-27 69.6
2024-05-08 61.4 2024-02-26 73.2
2024-05-07 58.8 2024-02-23 73.2
2024-05-06 60.7 2024-02-22 69.9
2024-05-03 62.5 2024-02-21 66.6
2024-05-02 63.1 2024-02-20 63.5
2024-04-30 62.4 2024-02-19 60.5
2024-04-29 62.1 2024-02-16 57.6
2024-04-26 60.7 2024-02-15 58.8
2024-04-25 62.1 2024-02-14 57.6
2024-04-24 62.6 2024-02-13 58.7
2024-04-23 62.7 2024-02-12 59.9
2024-04-22 61.9 2024-02-09 61.1
2024-04-19 57.9 2024-02-08 62.3
2024-04-18 57.9 2024-02-07 62.3
2024-04-16 58.4 2024-02-06 61.1
2024-04-15 57.4 2024-02-05 59.9
2024-04-12 57.5 2024-02-02 58.9
2024-04-10 59.7 2024-02-01 57.8
2024-04-09 57.1 2024-01-31 58.9
2024-04-08 55.3 2024-01-30 58.8
2024-04-05 52.7 2024-01-29 59.9
2024-04-04 51.7 2024-01-25 61.1
2024-04-03 50.7 2024-01-24 62.4
2024-04-02 49.8 2024-01-23 63.6
2024-04-01 50.8 2024-01-19 65.5
2024-03-28 51.8 2024-01-18 66.8
2024-03-27 52.8 2024-01-17 68.1
2024-03-26 53.9 2024-01-16 69.5
2024-03-22 53.9 2024-01-15 70.9
2024-03-21 54.9 2024-01-12 72.3
2024-03-20 56.0 2024-01-11 73.7
2024-03-19 57.1 2024-01-10 75.2
2024-03-18 56.4 2024-01-09 76.7

Hindustan Bio Sciences Ltd (BOM:532041) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.